Metabolic inflexibility is a hallmark of insulin resistance and can be extensively explored with high-throughput metabolomics techniques. However, the dynamic regulation of the metabolome during an oral glucose tolerance test (OGTT) in subjects with type 2 diabetes (T2D) is largely unknown. We aimed to identify alterations in metabolite responses to OGTT in subjects with T2D using untargeted metabolomics of both plasma and subcutaneous adipose tissue (SAT) samples. Twenty subjects with T2D and twenty healthy controls matched for sex, age, and body mass index (BMI) were profiled with untargeted metabolomics both in plasma (755 metabolites) and in the SAT (588) during an OGTT. We assessed metabolite concentration changes 90 min after the gluc...
Objective: We studied whether blood metabolomic measures in people with type 2 diabetes (T2D) are as...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...
Impaired insulin sensitivity (IS) is a major risk factor for cardiovascular disease and type 2 diabe...
Gas chromatography/mass spectrometry-based metabolomics was applied to investigate dynamic changes i...
Objective: Impaired glucose tolerance (IGT) is one of the presymptomatic states of type 2 diabetes m...
Insulin resistance (IR) predisposes to type 2 diabetes and cardiovascular disease but its causes are...
Aims/hypothesis: Circulating metabolites have been shown to reflect metabolic changes during the dev...
Aims/hypothesis Circulating metabolites have been shown to reflect metabolic changes during the deve...
Understanding the metabolic basis of glucose intolerances and insulin resistance is essential to fac...
Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring HU, Schleicher ED, Xu G, Lehmann R. Cha...
Insulin secretion following ingestion of a carbohydrate load affects a multitude of metabolic pathwa...
A number of metabolic conditions, including hypoglycemia, high blood pressure (HBP), dyslipidemia, n...
Insulin resistance progressing to type 2 diabetes mellitus (T2DM) is marked by a broad perturbation ...
Type 2 diabetes (T2D) and its comorbidities have reached epidemic proportions, with more than half a...
Objective: We studied whether blood metabolomic measures in people with type 2 diabetes (T2D) are as...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...
Impaired insulin sensitivity (IS) is a major risk factor for cardiovascular disease and type 2 diabe...
Gas chromatography/mass spectrometry-based metabolomics was applied to investigate dynamic changes i...
Objective: Impaired glucose tolerance (IGT) is one of the presymptomatic states of type 2 diabetes m...
Insulin resistance (IR) predisposes to type 2 diabetes and cardiovascular disease but its causes are...
Aims/hypothesis: Circulating metabolites have been shown to reflect metabolic changes during the dev...
Aims/hypothesis Circulating metabolites have been shown to reflect metabolic changes during the deve...
Understanding the metabolic basis of glucose intolerances and insulin resistance is essential to fac...
Zhao X, Peter A, Fritsche J, Elcnerova M, Fritsche A, Haring HU, Schleicher ED, Xu G, Lehmann R. Cha...
Insulin secretion following ingestion of a carbohydrate load affects a multitude of metabolic pathwa...
A number of metabolic conditions, including hypoglycemia, high blood pressure (HBP), dyslipidemia, n...
Insulin resistance progressing to type 2 diabetes mellitus (T2DM) is marked by a broad perturbation ...
Type 2 diabetes (T2D) and its comorbidities have reached epidemic proportions, with more than half a...
Objective: We studied whether blood metabolomic measures in people with type 2 diabetes (T2D) are as...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...
Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascu...